Study to Determine if a Reduction in Pain Can be Measured in Spinal Cord Injured Patients Using a New Study Design
Status:
Terminated
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The study is designed to assess if spinal cord injury patients have reduced pain after taking
either pregabalin or placebo in a cross over design. Patients had either pain at the level of
their injury or below the level of their injury.
Phase:
N/A
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.